Co-Authors
This is a "connection" page, showing publications co-authored by Sven Saussez and Giacomo De Riu.
Connection Strength
4.579
-
Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction. Indian J Otolaryngol Head Neck Surg. 2021 Aug 22; 1-2.
Score: 0.241
-
Correction to: Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2861.
Score: 0.240
-
Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients. Int Forum Allergy Rhinol. 2022 01; 12(1):103-107.
Score: 0.239
-
Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. Eur J Neurol. 2021 11; 28(11):3702-3711.
Score: 0.239
-
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? J Laryngol Otol. 2021 Aug; 135(8):723-728.
Score: 0.238
-
Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study. Pathogens. 2021 Jun 04; 10(6).
Score: 0.237
-
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study. Eur Arch Otorhinolaryngol. 2022 Feb; 279(2):811-816.
Score: 0.236
-
Chemosensory dysfunction in COVID-19: Is there really a correlation with viral load? Am J Otolaryngol. 2021 Jul-Aug; 42(4):103037.
Score: 0.235
-
Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients. Rhinology. 2021 Feb 01; 59(1):21-25.
Score: 0.232
-
Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2851-2859.
Score: 0.231
-
Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients. Pathogens. 2021 Jan 12; 10(1).
Score: 0.231
-
Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front Med (Lausanne). 2020; 7:582802.
Score: 0.229
-
Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J Laryngol Otol. 2020 Dec; 134(12):1123-1127.
Score: 0.228
-
Gustatory Dysfunction: A Highly Specific and Smell-Independent Symptom of COVID-19. Indian J Otolaryngol Head Neck Surg. 2020 Sep 30; 1-3.
Score: 0.226
-
ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review. Head Neck Pathol. 2021 Mar; 15(1):225-235.
Score: 0.225
-
Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020 Aug; 134(8):703-709.
Score: 0.224
-
Clinical and Radiological Evaluations of COVID-19 Patients With Anosmia: Preliminary Report. Laryngoscope. 2020 11; 130(11):2526-2531.
Score: 0.224
-
Do olfactory and gustatory psychophysical scores have prognostic value in COVID-19 patients? A prospective study of 106 patients. J Otolaryngol Head Neck Surg. 2020 Aug 06; 49(1):56.
Score: 0.224
-
Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients. Pathogens. 2020 Jul 31; 9(8).
Score: 0.224
-
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients. Laryngoscope. 2021 10; 131(10):2312-2318.
Score: 0.060
-
Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study. J Laryngol Otol. 2021 May; 135(5):436-441.
Score: 0.059
-
Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases. J Laryngol Otol. 2020 Jul; 134(7):571-576.
Score: 0.056